Bob A. Wise, MD

• Medical Director Pulmonary Function Laboratory, Johns Hopkins Asthma & Allergy Center

Professor of Medicine

• Global Health, Center for
• Scleroderma Center

Evaluate the Effect of Aclidinium Bromide on Long-term Cardiovascular Safety and Exacerbations in Moderate to Very Severe COPD Patients. (ASCENT COPD)

Losartan for treatment of Emphysema (LEEP)

Zinc Gluconate for Chronic Cough (ZICO)

• Stop Commonly Prescribing Stomach-Upset Drugs for Asthmatics without Serious Heartburn

Instructor in Radiology and Radiological Science

5501 Hopkins Bayview Circle
Baltimore, MD 21224

Asthma, COPD, Critical care medicine, Emphysema, Lung-volume reduction surgery, Pulmonary medicine, Scleroderma

Robert Wise Lab

• The Robert Wise Lab conducts clinical trials to study chronic obstructive lung diseases (COPD). We investigate inhaled corticosteroids in patients with mild to moderate COPD and the effectiveness of anti-inflammatories in allowing lung growth in mild to moderate asthmatic children. Our research includes exploring the efficacy of various treatments for asthmatic women who are pregnant and of lung-volume reduction surgery for emphysema patients. We also conduct studies of the clinical epidemiology, pathobiology and treatment of interstitial lung disease in patients with scleroderma.

Dr. Wise and his team conduct clinical trials to study chronic obstructive lung diseases (COPD) and asthma.  This includes pharmacologic agents, behavioral interventions, and devices. 

https://scholar.google.com/citations?user=ArrHoZwAAAAJ&hl=en